Tuesday , October 24 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 17)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

June 16, 2016

dave

Steve, Joy and I had full days at the ADA Scientific meeting last week. Steve and Joy were busy interviewing key opinion leaders and researchers, and I was combing the posters and abstracts looking for the latest data that affects your practice — and possibly your choice of medications. There were plenty ...

Read More »

June 14, 2016

dave

We are at the ADA in New Orleans and as I was looking over the posters, there was a whole section focused on Gene Expression and Biosynthesis. There were multiple small population projects on what might cause the mutations and proposed mechanisms to fix  or prevent the problems that these ...

Read More »

June 11, 2016

dave

Steve and I just got to New Orleans in time for the opening of the ADA Scientific Sessions, and already it looks like we are going to garner a lot of diabetes information in a short amount of time. As I was working on ideas for reporting, I noticed that there ...

Read More »

June 7, 2016

dave

23andMe:  I am sure you have seen the commercials on TV. This is a genetic test that you can get done to learn your ancestry: you simply spit into a tube, mail it away, and presto change-o, all the years of thinking you were from Italy can be erased in a ...

Read More »

June 4, 2016

dave

I was watching “Beyond the Tank” on TV last week. For those of you who are not familiar with that show, it is a followup to “Shark Tank” and looks at how businesses that the Sharks invested in are doing months later. This episode focused on Mission Belt company and ...

Read More »

May 31, 2016

dave

When you work with children with diabetes, you often find out that many times the parents blame themselves for causing the disease. After a time they move to overprotecting their children and keeping them from enjoying many of the fun things of life as they grow up. This constant banter ...

Read More »

May 28, 2016

dave

Back in December in my Editors Desk, I mentioned that a CDE/dietitian friend of mine enlightened me on the reasons that artificial sweeteners might have some effects on the gut flora of patients. Her solution was to start taking probiotics to correct the imbalance that was occurring. Over the years ...

Read More »

May 23, 2016

dave

In last week’s newsletter, we were discussing the melding of drugs and medical technology together to improve patient outcomes. This will be the wave of the future  as more Pharma companies enter into pay-for-performance contracts with insurers and better outcomes will be the only way they can be paid. This ...

Read More »

May 21, 2016

dave

This week, the FiercePharma website had a great article on pay-for-performance arrangements. Although these aren’t commonplace now, about 14% of U.S. payers have at least one pay-for-performance pricing arrangement, up from 10% in 2014, according to a new specialty reimbursement report from EMD Serono. Another 30% of plans say they’ll ...

Read More »

dave

Sometimes we are so interested in the process that we forget to look for the outcome with our patients. This means we take our diabetes patients and start low and go slow. This kind of treatment regimen may be following the “guidelines” but oftentimes getting to the goal we want ...

Read More »